What is the protocol for bone marrow examination in a patient with Pyrexia of Unknown Origin (PUO)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Protocol for Bone Marrow Examination in Pyrexia of Unknown Origin (PUO)

Bone marrow examination is not routinely indicated as a first-line investigation in all patients with PUO but should be performed selectively based on specific clinical indicators and after initial workup fails to identify the cause. 1, 2

Indications for Bone Marrow Examination in PUO

  • Bone marrow examination should be considered when there are unexplained cytopenias (anemia, leukopenia, thrombocytopenia) in patients with PUO 1, 3
  • It is particularly valuable in patients with involvement of reticuloendothelial organs (e.g., splenomegaly) 2, 3
  • Bone marrow biopsy has higher diagnostic yield in immunocompromised patients, especially those with HIV infection 4
  • Consider bone marrow examination in elderly patients with PUO as they have higher likelihood of hematological malignancies 2, 5
  • When other investigations including advanced imaging (CT, PET/CT) fail to identify the cause of fever 6, 5

When to Skip Bone Marrow Examination

  • In patients with suspected Hodgkin lymphoma, routine bone marrow biopsy may be omitted if PET scan is negative or shows homogeneous bone marrow uptake 7, 1
  • The bone marrow may be assumed to be involved if the PET scan displays multifocal (≥3) skeletal lesions 7
  • In typical cases of lymphomatoid papulosis (LYP) with absence of palpable enlarged lymph nodes, absence of hepatosplenomegaly, normal laboratory tests, and absence of B symptoms 7

Procedure Protocol

  • Both bone marrow aspiration and trephine biopsy should be performed concurrently for optimal diagnostic yield 3
  • Trephine biopsy offers significantly higher diagnostic yield (76%) compared to aspiration alone (16.5%) in PUO cases 3
  • Bone marrow samples should be processed for:
    • Morphological examination 3
    • Cultures for bacteria, mycobacteria, and fungi 4, 3
    • Immunohistochemistry for suspected lymphoma or other malignancies 1
    • Special stains for infectious organisms 3

Diagnostic Yield and Common Findings

  • Overall diagnostic yield of bone marrow examination in PUO ranges from 26-33% 4, 3
  • Common diagnoses established through bone marrow examination in PUO include:
    • Granulomatous diseases (tuberculosis, sarcoidosis, fungal infections) - most commonly detected on trephine biopsy 3
    • Hematological malignancies (lymphoma, leukemia) 1, 3
    • Leishmaniasis 3
    • Aplastic anemia or pure red cell aplasia 3

Practical Considerations

  • Granulomas are frequently found in trephine biopsies (70% of cases) but are rarely identified in aspiration smears (1.6%) 3
  • Bone marrow examination should be performed before starting empiric antimicrobial therapy to avoid false negative results 8
  • Consider the timing of bone marrow examination in relation to other diagnostic tests - ideally after non-invasive tests have been completed but before empiric therapy is initiated 6, 8

Common Pitfalls to Avoid

  • Relying solely on bone marrow aspiration without trephine biopsy significantly reduces diagnostic yield 3
  • Performing bone marrow examination too early in the diagnostic workup before completing basic investigations and imaging 6, 5
  • Failure to send bone marrow samples for appropriate microbiological cultures and special stains 4, 3
  • Starting empiric antimicrobial therapy before obtaining bone marrow samples 8

References

Guideline

Diagnostic Role of Bone Marrow Examination in Pyrexia of Unknown Origin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pyrexia of unknown origin.

Clinical medicine (London, England), 2018

Guideline

Diagnostic Approach to Pyrexia of Unknown Origin (PUO)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pyrexia of unknown origin--approach to management.

Singapore medical journal, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.